Literature DB >> 7331286

Effect of combined treatment of serum containing hepatitis B virus with beta-propiolactone and ultraviolet irradiation.

W Stephan, H Berthold, A M Prince.   

Abstract

The effect of cold sterilization by beta-propiolactone (beta-PL) and ultraviolet (UV) irradiation of serum contaminated with infectious hepatitis B virus (HBV) was investigated in chimpanzee. Chimpanzees given 0.1 ml/kg of the undiluted HBV serum estimated to contain 10(7)-10(8) CID50/ml developed acute hepatitis B infection 4 weeks after inoculation. Chimpanzees injected with the same undiluted hepatitis serum treated with beta-PL/UV developed hepatitis B infection 14 weeks later. Based on the published linear relationship between log dose of HBV and incubation period in chimpanzees this indicates a 10(6)-fold reduction in infectivity titer. Animals inoculated with the serum diluted 1:1,000 showed manifest hepatitis B infection 11 weeks later. Animals inoculated with serum diluted 1:1,000 and then cold sterilized with beta-PL/UV showed no signs of hepatitis B infection. Sensitive proteins are not denatured by beta-PL/UV cold sterilization.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7331286     DOI: 10.1111/j.1423-0410.1981.tb01026.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

Review 1.  The chimpanzee model for hepatitis B virus infection.

Authors:  Stefan F Wieland
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 2.  Transmission of diseases by blood transfusion.

Authors:  S Seidl; P Kühnl
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

3.  Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals.

Authors:  W W Bond; M S Favero; N J Petersen; J W Ebert
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

4.  Inactivation of hepatitis A virus added to pooled human plasma by beta-propiolactone treatment and ultraviolet irradiation.

Authors:  G G Frösner; W Stephan; H Dichtelmüller
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

5.  Hepatitis safety of a new prothrombin complex preparation, sterilized according to the method of LoGrippo. Results of a prospective clinical trial.

Authors:  I Hoppe
Journal:  Blut       Date:  1985-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.